Riskpilot← Back to searchSign inGet full accessDIAGNOSTRIX AS
ASActiveOrg 925098787Fosseikeveien 24, 4323 SandnesResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employees
Revenue 2024
NOK 238K
-32% vs 2023
EBITDA margin
-1614.7%
-3224% vs 2023
Equity ratio
-16.3%
Financial strength
Net profit 2024
NOK -3,9M
-1868% vs 2023
| Revenue | NOK 238K | -32% |
| EBITDA | NOK -3,8M | -3224% |
| Net profit | NOK -3,9M | -1868% |
| Total assets | NOK 7,7M | -1% |
| Equity | NOK -1,3M | -148% |
| Employees | 1 | — |
Legal name
DIAGNOSTRIX AS
Org number
925098787
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. mai 2020
Share capital
NOK 41 772
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive forskning og uvikling av produkter og tjenester innen diagnose for salg i et internasjonalt marked. Selskapet skal også levere konsulenttjenester. Selskapet skal også samarbeide med, og investere i, andre selskaper og alt som dertil står i forbindelse.
Address
Fosseikeveien 24, 4323 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 96 | 104 | 352 | 238 |
| Staff expenses | −0 | −321 | −134 | −238 | −548 |
| EBITDA | −1 284 | −153 | −21 | −115 | −3 836 |
| Depreciation & amort. | −1 | −6 | −18 | −18 | −13 |
| EBIT | −1 285 | −159 | −39 | −133 | −3 850 |
| Net financials | −6 | −37 | −84 | −63 | −22 |
| Profit before tax | −1 291 | −196 | −122 | −197 | −3 872 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 291 | −196 | −122 | −197 | −3 872 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 391 | 301 | 3 024 | 7 811 | 7 708 |
| Equity | −1 272 | −1 468 | −1 590 | 2 613 | −1 259 |
| Long-term debt | 1 500 | 1 650 | 4 265 | 500 | 300 |
| Short-term debt | 163 | 119 | 349 | 4 698 | 8 667 |
| Total debt | 1 663 | 1 769 | 4 614 | 5 198 | 8 967 |
EBITDA margin
-1614.7%
This company
15.8%
Market median
-10320% vs market
20202024
Equity ratio
-16.3%
This company
38.2%
Market median
-143% vs market
20202024
Return on equity
-387170900.0%
This company
18.4%
Market median
-2104189774% vs market
20202024
Net profit margin
-1629.5%
This company
8.1%
Market median
-20217% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
7.12×
This company
0.62×
Market median
-1048% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-03-19 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biolink Group As | Company | 57.3% | 57.3% | 2024 |
Oratel Diagnostics Llc | Company | 42.7% | 42.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DIAGNOSTRIX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Larsen | Chief Executive Officer | 0 companies |
| Svein Ove Føyen | Board of Directors | 0 companies |
| Kåre Svaboe | Chairman | 0 companies |
| Sjur Svaboe | Chairman | 0 companies |
| Linn Kathrine Høiland Sagerup | Board of Directors | 0 companies |
| Torleiv Bilstad | Board of Directors | 0 companies |